1. Home
  2. Analysis
  3. Zemuron
  4. Urticaria-aggravated

Zemuron and Urticaria aggravated - a phase IV clinical study of FDA data

Summary:

Urticaria aggravated is reported as a side effect among people who take Zemuron (rocuronium bromide), especially for people who are female, 50-59 old, also take Propofol, and have Neuromuscular blockade reversal.

The phase IV clinical study analyzes which people have Urticaria aggravated when taking Zemuron. It is created by eHealthMe based on reports of 872 people who have side effects when taking Zemuron from the FDA, and is updated regularly.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

What is Urticaria aggravated?

Urticaria aggravated (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,058 drugs and 721 conditions by eHealthMe. Check the latest studies of Urticaria aggravated.

On Aug, 01, 2026

872 people reported to have side effects when taking Zemuron.
Among them, 18 people (2.06%) have Urticaria aggravated.

Could Zemuron cause Urticaria aggravated?

Among these 18 people:

What is the gender of people who have Urticaria aggravated when taking Zemuron? *

  • female: 88.89 %
  • male: 11.11 %

What is the age of people who have Urticaria aggravated when taking Zemuron? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 12.5 %
  • 30-39: 6.25 %
  • 40-49: 25.0 %
  • 50-59: 37.5 %
  • 60+: 18.75 %

What are other drugs people take besides Zemuron? *

  1. Propofol: 11 people, 61.11%
  2. Fentanyl: 8 people, 44.44%
  3. Diprivan: 4 people, 22.22%
  4. Midazolam: 3 people, 16.67%
  5. Versed: 3 people, 16.67%
  6. Nitrous Oxide W/ Oxygen: 2 people, 11.11%
  7. Hydroxyzine: 2 people, 11.11%
  8. Wellbutrin: 2 people, 11.11%
  9. Xylocaine: 2 people, 11.11%
  10. Sublimaze: 2 people, 11.11%

What are other side effects people have besides Urticaria aggravated? *

  1. Hypotension (abnormally low blood pressure): 13 people, 72.22%
  2. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 8 people, 44.44%
  3. Acute Circulatory Failure (shock): 3 people, 16.67%
  4. Drug Hypersensitivity: 3 people, 16.67%
  5. Angioneurotic Oedema (swelling that occurs just beneath the surface of the skin or mucous membranes): 2 people, 11.11%
  6. Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 11.11%
  7. Heart Rate Increased: 2 people, 11.11%
  8. Heart Rate Decreased: 2 people, 11.11%
  9. Itching: 1 person, 5.56%
  10. Oedema Mouth (swelling of mouth): 1 person, 5.56%

What are the existing conditions these people have? *

  1. Neuromuscular Blockade Reversal: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Zemuron and have Urticaria aggravated?

- Check whether Urticaria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zemuron:

Urticaria aggravated treatments and more:

How severe was Urticaria aggravated and when was it recovered:

Expand to all the drugs that have ingredients of rocuronium bromide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zemuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria aggravated:

Browse all the conditions that are associated with Urticaria aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide (the active ingredients of Zemuron) and Zemuron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.